Related Experiment Videos
[Antitumor defense mechanisms in mice with progressively growing murine bladder tumor (MBT-2)]
1Department of Urology, Osaka City University Medical School.
Abstract:
MBT-2 in C3H/HeN mice was used as a model to examine cytotoxic activity. The cytotoxic activities examined were those of natural killer cells (NK), lymphokine activated killer cells (LAK), and tumorcidal macrophage (M psi). NK activity increased in early tumor bearers, but LAK and M psi activities increased in middle tumor bearers. NK activity was inhibited in late tumor bearers, but LAK and M psi activities were not inhibited. Cell surface markers and production of various cytokines were examined in order to analyze the changes in each activity.
Insights
Natural killer (NK) cell activity increased early in tumor-bearing mice but decreased later. Conversely, lymphokine-activated killer (LAK) and tumor-icidal macrophage (M psi) activities rose in middle stages and were not inhibited in late stages.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Context:
- Investigating the dynamic changes in anti-tumor immune responses during tumor progression.
- Utilizing the MBT-2 tumor model in C3H/HeN mice to simulate cancer development.
- Examining the roles of Natural Killer (NK) cells, Lymphokine-Activated Killer (LAK) cells, and tumor-icidal macrophages (M psi) in anti-tumor immunity.
Purpose:
- To analyze the distinct temporal patterns of NK, LAK, and M psi cell activities during tumor progression.
- To understand the underlying mechanisms, including cell surface marker expression and cytokine production, that drive these changes.
- To differentiate the immune evasion strategies employed by tumors at various stages.
Summary:
- NK cell activity peaked in early tumor bearers and was suppressed in late stages.
- LAK and M psi cell activities showed a delayed increase, peaking in middle tumor bearers and remaining elevated in late stages.
- Analysis of cell surface markers and cytokine profiles provided insights into the modulation of these cytotoxic activities.
Impact:
- Provides a comprehensive understanding of the evolving immune landscape during cancer development.
- Highlights the differential roles and temporal dynamics of key immune cell populations in tumor surveillance and elimination.
- Offers potential targets for immunotherapeutic interventions tailored to specific tumor stages.